GE HealthCare Technologies Inc. is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator. The company's mission is to create a world where healthcare has no limits. GE HealthCare operates at the center of the healthcare ecosystem, enabling precision care by increasing health system capacity, enhancing productivity, digitizing healthcare delivery, and improving clinical outcomes. The company generates revenue from the sale of medical devices, consumable products, service capabilities, and digital solutions. The company's scale and breadth of portfolio, combined with innovation capabilities, position it to be a leading enabler of precision care. GE HealthCare serves customers in approximately 160 countries.

The company's competitive advantages include its strong reputation built over 125 years, broad service capabilities, and a strong operational culture.

• Employees: approximately 51,000
• Geographic Footprint: approximately 160 countries
• Headquarters: Chicago, Illinois
• Founded: 2023 (Spin-Off from GE)
• Number of manufacturing, assembly, and pharmaceutical production sites: 43 across 17 countries
• Revenue: $19.552 billion (FY2023)
• Key Subsidiaries/Brands: Molecular Imaging, Computed Tomography, Magnetic Resonance, Image-Guided Therapies, Women's Health, X-ray, Ultrasound, Patient Care Solutions, Pharmaceutical Diagnostics

• CEO: Peter J. Arduini
• CFO: James K. Saccaro
• General Counsel and Corporate Secretary: Frank R. Jimenez
• Chief Science and Technology Officer: Taha Kass-Hout
• Chief People Officer: Betty D. Larson
• CEO, Imaging: Jan Makela
• CEO, Pharmaceutical Diagnostics: Kevin M. O'Neill
• CEO, Ultrasound: Roland Rott
• Chief Global Supply Chain and Service Officer: Kenneth Stacherski
• CEO, Patient Care Solutions: Thomas J. Westrick

Key leaders are industry veterans with skills and expertise to lead a large, publicly listed medical technology, pharmaceutical diagnostics, and digital solutions company.

• Annual Revenue: $19.552 billion (FY2023)
• Net Income: $1.568 billion
• Total Assets: $32.454 billion
• Number of Employees: approximately 51,000
• Key Financial Highlights: Revenue increased by 7% year-over-year, primarily due to sales of products. Net income decreased by 18% year-over-year.

GE HealthCare offers a broad portfolio of products, services, and digital solutions across four segments:

• Imaging: Scanning devices, clinical applications, service capabilities, and digital solutions including Molecular Imaging, Computed Tomography, Magnetic Resonance, Image-Guided Therapies, Women's Health, and X-ray.
• Ultrasound: Ultrasound medical devices and solutions for screening, diagnosis, treatment, and monitoring, including Radiology and Primary Care, Women's Health, Cardiovascular, Point of Care and Handheld, and Surgical Visualization and Guidance.
• Patient Care Solutions: Medical devices, consumables, services, and digital solutions including Patient Monitoring, Anesthesia Delivery and Respiratory Care, Diagnostic Cardiology, Maternal Infant Care, and Consumables and Services.
• Pharmaceutical Diagnostics: Diagnostic agents for radiology and nuclear medicine including Contrast Media and Molecular Imaging.

The company is organized into four business segments:

• Imaging: A global leader in medical imaging with a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions.
• Ultrasound: A global leader in ultrasound medical devices and solutions with a broad portfolio that spans the continuum of care.
• Patient Care Solutions: A leading global provider of medical devices, consumables, services, and digital solutions that acquire and transform complex clinical data into real-time visualization and clinical decision support.
• Pharmaceutical Diagnostics: A leading supplier of diagnostic agents to the global radiology and nuclear medicine industry.

Revenue breakdown by segments for FY2023:

• Imaging: $10.581 billion
• Ultrasound: $3.457 billion
• Patient Care Solutions: $3.142 billion
• Pharmaceutical Diagnostics: $2.306 billion

GE HealthCare's business strategy includes the acquisition of technologies and businesses that expand or complement its existing business. The company focuses on creating new products and solutions, developing new applications for products, and enhancing existing products to help improve outcomes for customers and their patients. Key strategic initiatives include: expanding access to healthcare; promoting inclusion and diversity; mitigating climate impact; advancing the circular economy; and protecting patient data and cybersecurity. The company is also focused on and investing in cloud, edge, Al, and software offerings. The company's growth strategy is underpinned by resilient, sustainable practices and products, and a commitment to growing access to care.

GE HealthCare operates in the highly competitive global medical technology industry. The company faces a wide variety of competitors, including manufacturers, third-party distributors, and service providers. Primary global competitors include Siemens Healthineers, Philips Healthcare, Canon, Mindray, and United Imaging. In the PDx business segment, the company primarily competes with Bayer, Bracco, Guerbet, Lantheus, and Curium. The company's ability to compete successfully may be affected by factors such as the introduction of new or more affordable products by competitors, the development of new technology, competitors responding more quickly to new technology, and a failure to satisfy local market conditions and regulations.

• Market Risks: Operating in highly competitive markets, competition may increase in the future, and the industry may be disrupted, requiring the company to lower prices or resulting in a loss of market share.
• Operational Risks: Inability to manage the supply chain or obtain supplies of components or raw materials, which has restricted, and could continue to restrict, the manufacturing of products, cause delays in delivery, or significantly increase costs. Any interruption in the operations of manufacturing facilities, or its suppliers' or customers' facilities, may impair the ability to deliver products or provide services. Reliance on third parties to help perform logistics, transportation, shipping, warehousing, and services functions on its behalf, and disruptions at these third-party providers could adversely affect its business.
• Financial Risks: Significant postretirement benefit liabilities, including pension, healthcare, and life insurance benefits obligations, and the actual costs and related cash flows of these obligations are uncertain and could exceed current estimates. Level of indebtedness, as well as its general ability to comply with covenants under debt instruments, could adversely affect its business, results of operations, cash flows, and financial condition.
• Regulatory Risks: Subject to stringent privacy laws and information security policies and regulations. Failure to comply with the FCPA and similar anti-corruption and anti-bribery laws globally has resulted and could continue to result in civil or criminal sanctions and adversely affect its business. Subject to anti-kickback and false claims laws, and failure to comply with these laws could adversely affect its business. Subject to antitrust and competition laws that can result in sanctions and conditions on the way the company conducts its business.